Swiss National Bank Biocryst Pharmaceuticals Inc Transaction History

Swiss National Bank

$143 Billion
Q2 2024

A detailed history of Swiss National Bank transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 363,968 shares of BCRX stock, worth $3.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

363,968

Previous 363,968 -0.0%

Holding current value

$3.07 Million

Previous $1.85 Million 21.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$4.89 - $7.65 $46,455 - $72,675	-9,500 Reduced 2.54%	363,968 $1.85 Million
Q4 2023 Feb 06, 2024	SELL	$4.98 - $6.77 $208,662 - $283,663	-41,900 Reduced 10.09%	373,468 $2.24 Million
Q3 2023 Nov 08, 2023	BUY	$6.71 - $7.92 $33,550 - $39,600	5,000 Added 1.22%	415,368 $2.94 Million
Q2 2023 Aug 09, 2023	BUY	$6.96 - $8.81 $55,680 - $70,480	8,000 Added 1.99%	410,368 $2.89 Million
Q1 2023 May 10, 2023	SELL	$7.94 - $11.84 $370,004 - $551,744	-46,600 Reduced 10.38%	402,368 $3.36 Million
Q4 2022 Feb 08, 2023	BUY	$10.5 - $14.2 $92,400 - $124,960	8,800 Added 2.0%	448,968 $5.15 Million
Q3 2022 Nov 09, 2022	BUY	$10.79 - $14.81 $56,107 - $77,012	5,200 Added 1.2%	440,168 $5.55 Million
Q2 2022 Aug 09, 2022	BUY	$7.89 - $17.88 $74,955 - $169,860	9,500 Added 2.23%	434,968 $4.6 Million
Q1 2022 May 09, 2022	BUY	$11.56 - $19.76 $380,324 - $650,104	32,900 Added 8.38%	425,468 $6.92 Million
Q3 2021 Nov 08, 2021	BUY	$14.21 - $17.65 $38,367 - $47,654	2,700 Added 0.69%	392,568 $5.64 Million
Q2 2021 Aug 06, 2021	SELL	$9.5 - $17.24 $129,200 - $234,463	-13,600 Reduced 3.37%	389,868 $6.16 Million
Q1 2021 May 07, 2021	BUY	$7.37 - $13.61 $31,691 - $58,523	4,300 Added 1.08%	403,468 $4.1 Million
Q4 2020 Feb 05, 2021	BUY	$3.37 - $8.61 $23,253 - $59,408	6,900 Added 1.76%	399,168 $2.97 Million
Q3 2020 Nov 09, 2020	BUY	$3.43 - $5.53 $22,638 - $36,498	6,600 Added 1.71%	392,268 $1.35 Million
Q2 2020 Aug 05, 2020	BUY	$1.9 - $5.61 $165,049 - $487,329	86,868 Added 29.07%	385,668 $1.84 Million
Q1 2020 May 08, 2020	BUY	$1.6 - $4.11 $23,680 - $60,828	14,800 Added 5.21%	298,800 $598,000
Q4 2019 Feb 06, 2020	BUY	$1.59 - $3.45 $229,119 - $497,145	144,100 Added 103.0%	284,000 $980,000
Q1 2019 May 10, 2019	BUY	$7.38 - $9.72 $33,210 - $43,740	4,500 Added 3.32%	139,900 $1.14 Million
Q4 2018 Feb 13, 2019	BUY	$6.51 - $9.6 $100,254 - $147,840	15,400 Added 12.83%	135,400 $1.09 Million
Q2 2018 Aug 09, 2018	SELL	$4.6 - $6.52 $235,979 - $334,476	-51,300 Reduced 29.95%	120,000 $688,000
Q3 2017 Nov 03, 2017	BUY	$4.1 - $5.97 $702,329 - $1.02 Million	171,300	171,300 $898,000

Others Institutions Holding BCRX

# of Institutions

257

Shares Held

173M

Call Options Held

397K

Put Options Held

444K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.57B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Biocryst Pharmaceuticals Inc Transaction History